189 related articles for article (PubMed ID: 36472914)
21. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
22. MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis.
Li H; Chen Z; Zhang Y; Yuan P; Liu J; Ding L; Ye Q
Cancer Lett; 2021 Oct; 519():161-171. PubMed ID: 34303763
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2/CES1 Signaling Pathway.
He W; Xu Y; Ren X; Xiang D; Lei K; Zhang C; Liu D
Dig Dis Sci; 2019 Nov; 64(11):3182-3191. PubMed ID: 31076985
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Regulation of Carboxylesterase 1 in Human Liver: Role of the Nuclear Receptor Subfamily 1 Group H Member 3 and Its Splice Isoforms.
Collins JM; Lu R; Wang X; Zhu HJ; Wang D
Drug Metab Dispos; 2022 Jan; 50(1):43-48. PubMed ID: 34697082
[TBL] [Abstract][Full Text] [Related]
25. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
[TBL] [Abstract][Full Text] [Related]
26. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
27. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
28. Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis.
Xu J; Li Y; Chen WD; Xu Y; Yin L; Ge X; Jadhav K; Adorini L; Zhang Y
Hepatology; 2014 May; 59(5):1761-1771. PubMed ID: 24038130
[TBL] [Abstract][Full Text] [Related]
29. Functional Study of Carboxylesterase 1 Protein Isoforms.
Wang X; Shi J; Zhu HJ
Proteomics; 2019 Feb; 19(4):e1800288. PubMed ID: 30520264
[TBL] [Abstract][Full Text] [Related]
30. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
31. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
[TBL] [Abstract][Full Text] [Related]
32. Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma.
Capece D; D'Andrea D; Begalli F; Goracci L; Tornatore L; Alexander JL; Di Veroli A; Leow SC; Vaiyapuri TS; Ellis JK; Verzella D; Bennett J; Savino L; Ma Y; McKenzie JS; Doria ML; Mason SE; Chng KR; Keun HC; Frost G; Tergaonkar V; Broniowska K; Stunkel W; Takats Z; Kinross JM; Cruciani G; Franzoso G
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33878036
[TBL] [Abstract][Full Text] [Related]
33. Defects in long-chain 3-hydroxy acyl-CoA dehydrogenase lead to hepatocellular carcinoma: A novel etiology of hepatocellular carcinoma.
Khare T; Khare S; Angdisen JJ; Zhang Q; Stuckel A; Mooney BP; Ridenhour SE; Gitan RS; Hammoud GM; Ibdah JA
Int J Cancer; 2020 Sep; 147(5):1461-1473. PubMed ID: 32115688
[TBL] [Abstract][Full Text] [Related]
34. Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.
Sanford JC; Wang X; Shi J; Barrie ES; Wang D; Zhu HJ; Sadee W
Pharmacogenet Genomics; 2016 May; 26(5):197-207. PubMed ID: 26871237
[TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.
Wang X; Rida N; Shi J; Wu AH; Bleske BE; Zhu HJ
Drug Metab Dispos; 2017 Nov; 45(11):1149-1155. PubMed ID: 28838926
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
37. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.
Wu JM; Skill NJ; Maluccio MA
HPB (Oxford); 2010 Nov; 12(9):625-36. PubMed ID: 20961371
[TBL] [Abstract][Full Text] [Related]
38. Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury.
Xu J; Xu Y; Li Y; Jadhav K; You M; Yin L; Zhang Y
Sci Rep; 2016 Apr; 6():24277. PubMed ID: 27075303
[TBL] [Abstract][Full Text] [Related]
39. Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition.
Hu ZY; Edginton AN; Laizure SC; Parker RB
Clin Pharmacokinet; 2014 Sep; 53(9):825-36. PubMed ID: 25103325
[TBL] [Abstract][Full Text] [Related]
40. Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.
Bansal S; Berk M; Alkhouri N; Partrick DA; Fung JJ; Feldstein A
J Surg Res; 2014 Jan; 186(1):29-38. PubMed ID: 24135379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
